Impending Market Shock: Tech Stocks and Trend Reversal
A major market shock is expected on Monday due to the buyback blackout period beginning. Tech stocks may be impacted, with signs of a trend reversal.
00:00:00 A major market shock is expected on Monday due to the buyback blackout period beginning. The decline in corporate stock buybacks could cause stocks to go down, impacting the equity market. Machines are predicted to react to this news.
📉 A major market shock is expected on Monday due to the buyback blackout period beginning, which historically leads to a decline in stock prices.
💲 Corporate stock buybacks have been the major driver of equity purchases, with authorization reaching 789 billion dollars year to date.
📊 Goldman predicts a 30 to 50 percent decline in trading volume during the blackout period, signaling a significant impact on the market.
00:02:59 Negative sentiment and positioning suggest that the S&P is likely to go down due to the worst technical setup of 2023. Machine positioning, both in U.S. equities and global equities, supports this downward momentum. Traders should be cautious during this Blackout Window.
💡 Negative sentiment and positioning indicate a major market shock is expected.
⚠️ Machines' positioning in US and global equities suggest a downward trend.
📉 Technical signals show a potential decrease in momentum.
00:05:57 A market shock is expected to hit soon as key indicators suggest a potential downside move. Tech stocks may be impacted, with signs of a trend reversal. Bond positioning indicates a higher buying price for the 10-year treasury note.
📊 The S&P is showing signs of a lower high, indicating a potential downside move.
💻 Momentum in the tech sector is slowing down and rolling over, with concerns about tech companies buying back stocks.
📉 The QQQ is also showing signs of a lower high, suggesting a possible market decline.
00:08:54 A market shock is expected on Monday. TLT has negative momentum. Gold may form a topping pattern and is more likely to be sold.
💼 TLT momentum is negative, with a consecutive daily sell signal, suggesting a downward trend.
📈 On the upside, adding another position on TLT when it moves off the Max short is recommended with a target of 97.25.
🔍 Gold is forming a massive topping pattern, indicating it's more likely to be sold than bought.
00:11:53 A market shock is predicted, with signs of a topping pattern and weakening momentum. Silver and GDX also show indications of a breakdown. King Joller is overbought.
📈 The 100-day moving average indicates a topping pattern, suggesting people are selling.
📉 GDX shows signs of a topping pattern, with sellers waiting for buyers to come in.
⚠️ There is a potential major buying opportunity if GDX drops to around 18.
📉 Silver is likely to break down, with negative momentum and consecutive sell signals.
📉 SLV has a topping pattern, with sellers above and a potential target of 18.
📈 Momentum is positive for King Joller, suggesting it is overbought.
00:14:50 A market shock is predicted to hit on Monday. The Invesco dollar bearish fund shows signs of reversal, while Platinum and Mira Pharmaceuticals present potential opportunities.
🔎 The Invesco dollar bearish fund (UDN) shows potential for a reversal in the dollar's downward trend.
💰 The Platinum trade demonstrates multiple buying opportunities and the potential for a positive return.
💁 Mira Pharmaceuticals (MIRA) is a promising stock with the potential for a significant upside movement.
00:17:48 A major market shock hits on Monday and the stock has been massively oversold. There is potential for a rally with a target price of around $4.5. This is a risky investment due to the company's pre-clinical stage.
📈 The stock of Mira 1A has experienced a massive wave of selling and is now considered massively oversold.
💊 Mira 1A is a prescription medication being developed with a better side effect profile and is focused on three therapeutic areas: neuropathic pain, anxiety, and cognitive decline.
🔬 Mira 1A has demonstrated its ability to enhance memory, improve cognitive performance, reduce pain, and relieve anxiety in pre-clinical research.
Want to deep dive into this video?
